Alastair L Parkes

Title: Alastair L Parkes: Innovator in Medicinal Chemistry

Introduction

Alastair L Parkes is a notable inventor based in Reading, GB. He has made significant contributions to the field of medicinal chemistry, holding a total of 3 patents. His work primarily focuses on developing innovative solutions for medical applications, particularly in the treatment of diseases characterized by excessive or abnormal cell proliferation.

Latest Patents

One of his latest patents involves the development of 6-alkynylpyridines, which are identified as SMAC mimetics. These compounds are particularly useful as medicaments for treating conditions such as cancer. The innovative nature of these compounds highlights their potential in addressing critical health challenges. Another patent focuses on merger and acquisition data validation. This invention provides systems and methods that perform data validation in real time. Users can upload source data from spreadsheets or enter it directly into an application, allowing for immediate validation and reporting. Once the data set passes all validations, it is forwarded to the technical team for upload into the transactional system.

Career Highlights

Throughout his career, Alastair has worked with prominent companies such as Oracle International Corporation and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in both technology and pharmaceuticals.

Collaborations

Alastair has collaborated with notable colleagues, including Ravi Manjunatha and David James Hallett. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Alastair L Parkes stands out as an influential inventor in the realm of medicinal chemistry. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.